Lowe D G, Ricketts M, Levinson A D, Goeddel D V
Department of Molecular Biology, Genentech, Inc., South San Francisco, CA 94080.
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1015-9. doi: 10.1073/pnas.85.4.1015.
The biological role of amino acid differences between the human 21-kDa Ha-ras protein (p21) and the human 23-kDa R-ras protein (p23) was investigated by engineering mutant Ha-ras p21 molecules containing divergent amino acid sequences from R-ras p23. Variant amino acids from R-ras p23 regions 1-30, 52-57, 67-78, 1-30 and 67-78 together, and 112-124 were substituted for the corresponding Ha-ras p21 amino acid regions 1-4, 26-31, 41-52, 1-4 and 41-52 together, and 86-98, respectively. Rat fibroblasts transfected with genes encoding these position-12 valine-substituted chimeric Ha-ras proteins displayed the same properties of morphological transformation and anchorage-independent growth as Ha-ras T24 oncogene-transformed fibroblasts. However, substitution of variant amino acids from the 80 C-terminal residues (amino acids 138-218) of R-ras p23 for the corresponding p21 amino acids (residues 112-189) inactivated the transforming activity of position-12 valine-substituted p21. The converse substitution of Ha-ras p21 C-terminal residues into R-ras p23 did not result in transformation by position-38 valine-substituted p23. These data are discussed in terms of the structure of ras proteins and the nature of interactions determining the specificity of effector function.
通过构建含有与R-ras p23不同氨基酸序列的突变型Ha-ras p21分子,研究了人类21-kDa Ha-ras蛋白(p21)与人类23-kDa R-ras蛋白(p23)之间氨基酸差异的生物学作用。将R-ras p23区域1-30、52-57、67-78、1-30和67-78一起以及112-124的变异氨基酸分别替换为相应的Ha-ras p21氨基酸区域1-4、26-31、41-52、1-4和41-52一起以及86-98。用编码这些第12位缬氨酸取代的嵌合Ha-ras蛋白的基因转染的大鼠成纤维细胞表现出与Ha-ras T24癌基因转化的成纤维细胞相同的形态转化和不依赖贴壁生长的特性。然而,用R-ras p23的80个C末端残基(氨基酸138-218)的变异氨基酸替换相应的p21氨基酸(残基112-189)会使第12位缬氨酸取代的p21的转化活性失活。将Ha-ras p21的C末端残基反向替换到R-ras p23中,不会导致第38位缬氨酸取代 的p23发生转化。根据ras蛋白的结构和决定效应器功能特异性的相互作用的性质对这些数据进行了讨论。